MedSchool: Ace Your OSCEsThe Medical Company
GET - On the App Store
Drug Guide


    IV / Subcut
    • Mechanism of Action
    • A fusion protein with the Fc fragment of human IgG1 linked to the extracellular domain of CTLA-4. Binds to CD80 / CD86 on antigen presenting cells and prevents binding by CD28 on T lymphocytes, resulting in lack of a costimulatory response and reduced T cell activation.

Clinical Use

    • Indications
    • Contraindications
    • Not to be used concurrently with other biologic DMARDs.
    • Adverse Effects
Want more info like this?
  • Your electronic clinical medicine handbook
  • Guides to help pass your exams
  • Tools every medical student needs
  • Quick diagrams to have the answers, fast
  • Quizzes to test your knowledge
Sign Up Now